ISAAR & ICIC 2017

Scientific Program

Symposium 1
09:00 ~ 11:00 Community-associated MRSA infections
S1-1 Unique Evolution of CA-MRSA Clones
Geoffrey Coombs, Murdoch University, Australia
S1-2 CA-MRSA as a new nosocomial pathogen
Doo-Ryeon Chung, Samsung Medical Center, Korea
S1-3 A vaccine for Staphylococcus aureus?
Robert Daum, The University of Chicago, USA
S1-4 Treatment options for CA-MRSA infections
Ian Gould, NHS Grampian, UK
Symposium 2
09:00 ~ 11:00 Emerging viral infections and vaccines
S2-1 Recent highly pathogenic avian influenza outbreaks by H5N6 and H5N8 viruses and molecular risk assessment of mammalian pathogenicity
Hyuk-Joon Kwon, Seoul National University, Korea
S2-2 Virological and immunological responses in MERS patients
Nam-Hyuk Cho, Seoul National University College of Medicine, Korea
S2-3 Clinical, epidemiological, and virological aspects of SFTS in Japan: what we have learned and what we should do?
Masayuki Saijo, National Institute of Infectious Diseases, Japan
S2-4 Infectious Diseases in the 21st Century: A Battle Plan for Survival
Michael Osterholm, University of Minnesota, USA
Symposium 3
09:00 ~ 11:00 Colistin-resistant gram-negatives
S3-1 Colistin resistance in gram-negatives
Po-Ren Hsueh, National Taiwan University Hospital, Chinese Taipei
S3-2 Emergence of mcr-1 colistin resistance: a new story begins
Eun-Jeong Yoon, Research Institute of Bacterial Resistance, Korea
S3-3 What to use in the clinical practice?
Yohei Doi, University of Pittsburgh, USA
S3-4 Colistin resistance: is it preventable?
Anucha Apisarnthanarak, Thammasat University Hospital,
Thailand
Plenary Lecture 1
11:10 ~ 11:50 Telehealth: new and important ways to treat infections
Franklin Cockerill, Analyte Health, USA
P1-1
Plenary Lecture 2
11:50 ~ 12:30 Vaccines against emerging infections: where are we?
Jerome Kim, International Vaccine Institute
P2-1
Oral Presentation 1
15:00 ~ 16:00 (7 minutes presentation & 3 minutes Q&A)
O1-GP01 A Multicenter Study of Clinical Features and Organisms Causing Community-Onset Cellulitis in Korea
Seong Yeon Park, Korea
O1-GP02 Prevalence and antimicrobial resistance of methicillin-resistant and susceptible Staphylococcus pseudintermedius (MRSP) isolated from dogs in veterinary hospitals in Korea
ChanHee LEE, Korea
O1-GP03 Minimum Inhibitory Concentration of Vancomycin to Methicillin Resistant Staphylococcus aureus (MRSA) isolated at a Tertiary Care Hospital in Sri Lanka
Nilanthi Senanayake, SriLanka
O1-GP04 Synergistic combination of antibiotics targeting identical subcellular structure with different mechanism to prevent antimicrobial resistance
Ganjun Yuan, China (P.R.C)
O1-GP05 THE ROLE OF TOLL-LIKE RECEPTORS IN PATHOGENESIS OF PNEUMOCOCCI OF VARIOUS SEROTYPES
Navindra Kumari Palanisamy, Malaysia
O1-GP06 Disease, serotypes and in-vitro antimicrobial susceptibilities of Streptococcus pneumoniae from hospitalized adult patients in Hong Kong, 2012 – 2014
Reema Subramanian, Hong Kong China
Oral Presentation 2
15:00 ~ 16:00 (7 minutes presentation & 3 minutes Q&A)
O2-GN01 Evaluation of multi drug resistant E.coli isolates and the role of Polymyxin B in urinary tract infections
Kalyan Koganti, India
O2-GN02 Outbreak of Colistin-Resistant KPC-2 Carbapenemase-Producing Klebsiella pneunoniae in Medical Intensive Care Unit
Se Ju Lee, Korea
O2-GN03 Antimicrobial Susceptibility and Molecular Characterization of Acinetobacter baumannii in Malaysia
Eng Hwa Wong, Malaysia
O2-GN04 Temporal relationship between β-lactam and β-lactamase inhibitor combinations and Klebsiella pneumoniae resistance to piperacillin/tazobactam
Sukhyun Ryu, Korea
O2-GN05 Study for Monitoring Antimicrobial Resistance Trends (SMART) in Australia and New Zealand (ANZ), 2002-2016
Ivana Rapajic-Moran, Australia
O2-GN06 Forecast of global antimicrobial resistance of Escherichia coli and Klebsiella pneumoniae in invasive isolates: a population weighted mixed linear mathematical model .
Gerardo Alvarez-Uria, India
Symposium 4
16:00 ~ 17:30 Carbapenem-resistant Enterobacteriaceae
S4-1 Carbapenemases from KPC to NDM to OXA-48: diverse enzymes in diverse clones
David Livermore, University of East Anglia, UK
S4-2 Diagnostic challenges in detecting carbapenem resistance
Kyungwon Lee, Yonsei University College of Medicine, Korea
S4-3 Antimicrobial treatment; recommendation and options for carbapenem-resistant Enterobacteriaceae
Ami Neuberger, Rambam Medical Center, Israel
Symposium 5
16:00 ~ 17:30 One world, one health
S5-1 One Health lessons from investigation emerging viruses of bat origin
Linfa Wang, Duke-NUS Medical School, Singapore
S5-2 One health approaches to zoonotic diseases and AMR
Yong Ho Park, Seoul National University, Korea
S5-3 One health activities on Nipah in Bangladesh: a high risk country for zoonotic disease spillover to man
John Clemens, International Center for Diarrhoeal Disease Research, Bangladesh (icddr,b), Bangladesh
Symposium 6
16:00 ~ 17:30 Pediatric mycoplasmal infections
S6-1 Mycoplasma pneumoniae Infection in Children
Cheng-Hsun Chiu, Chang Gung Children's Hospital, Chinese Taipei
S6-2 Macrolide-resistant Mycoplasma pneumoniae pneumonia in children
Eun Hwa Choi, Seoul National University College of Medicine, Korea
S6-3 Management of severe mycoplasma infection: role of antibiotics and steroid
Nancy Henry, Mayo Clinic, USA